Qool Therapeutics snags $8 mln
Silicon Valley-based Qool Therapeutics, a developer of a targeted temperature management system, has raised $8 million in funding. The investors were Zhongji Holdings LTD/Join Medical Technology, TAMCAP LLC, BrilliMedical International Corp., BioPacific Investors, Western Technology Investment and FundRx.
28 November 2017•3 mins read
